-
Pharma conference digs into Gilead case, executive orders, CMS audits
At the annual pharmaceutical compliance event, speakers discussed the Gilead False Claims Case and Trump administration initiatives.
-
Pharmaceutical Compliance Congress: Panelists spot trends to prioritize in 2025
At the annual pharmaceutical compliance event, panelists said the time for an empowered compliance department engaged in mindful monitoring is now.
-
Attorneys Kudman and Posner on strategies to detect and deter healthcare fraud
We discussed improper marketing strategies, upcoding and billing issues, defense strategies for fraud cases with Tama Kudman and Barry Posner.
-
Pfizer and Novo Nordisk rebuked over pharma payments
Two cases involving pharmaceutical companies highlight importance of adequate disclosure over payments to healthcare groups.
-
DOJ pilot program offers leniency for some executive criminal tipsters
Pilot program at DOJ will give immunity to executives providing information about corporate misconduct in which they were involved.
-
UK reinsurance brokers settle FCPA charges with DOJ
Millions of dollars in bribes were paid to Ecuadorian government officials.